Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade)

Company Overview - Kura Oncology, Inc. is a clinically staged biopharma company established in 2014 and headquartered in San Diego, California [1] - The company focuses exclusively on the development of small-molecule drugs informed by patient selection biomarkers [1] Leadership and Background - The company has a co-founder with a Ph.D. in organic synthesis from Stanford University and experience working for major pharmaceutical companies like Merck [1] - The co-founder has also worked in biotech startups and was the first employee of 1200 Pharma, which garnered significant investment [1] Investment Focus - The company is noted for its focus on market trends, particularly in biotechnology stocks [1]